| Fund ID | 805-9903208593 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 5% |
| Owned by funds of funds | 16% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Bios Fund III Qp, LP | Venture Capital | $83.7M |
| Bios Fund II Qp, LP | Venture Capital | $22.2M |
| Bios Actuate Co-Invest II, LP | Venture Capital | $16.7M |
Bios Incycus Co-Invest I, LP reports $257,582 in gross assets, among the top 98% of private funds by size.
The stated minimum investment is $1,000.
Bios Incycus Co-Invest I, LP is managed by Steelhead Capital Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.